Our highlighted selection of Covid-related interventional studies with open label or non-randomised methodology from the scientific press for January 2022

Our highlighted selection of Covid-related obeservational studies from the scientific press for January 2022

Part 2 of our highlighted selection of Covid-related cross-sectional case control studies from the scientific press for January 2022

Part 1 of our highlighted selection of Covid-related cross-sectional case control studies from the scientific press for January 2022

Our highlighted selection of Covid-related case series and case reports from the scientific press for January 2022

Our highlighted selection of Covid-related expert opinions from the scientific press for January 2022

Our highlighted selection of miscellaneous Covid-related studies from the scientific press for January 2022

Our highlighted selection of Covid-related Literature Reviews from the scientific press for January 2022.

The EAN Education Committee is happy to announce the selection of candidates for the Clinical Fellowship Programme 2022.

With so few chances for EAN staff and members to meet in person, we decided to introduce the team behind the scenes. This time it's Lucia, Head of the Memberhip and Scientific Departments, and Anja, from the Communications Department.

EAN Programme Committee Chair, Tony Marson, on abstract submission, registration and the preliminary programme for EAN 2022.

Our research paper of the month is a multicentre, randomised and double-blind phase 2 study with a futility design, exploring the efficacy and the safety of guanabenz in patients with probable or definite amyotrophic lateral sclerosis (ALS).

Our authors of the month conducted a systematic review of SARS-CoV-2-associated deaths in Hamburg, Germany, from March to December 2020, using conventional autopsy, ultrasound-guided minimally invasive autopsy, postmortem computed tomography (PMCT) and medical record review.

On 30 November the European Brain Council held an event to build on the latest discussions on the Declaration on Good Off-Label Use Practices.

The OneNeurology European Summit took place on 17 December 2021 under the patronage of the Slovenian Presidency in the Council of the EU